Frontiers in CAR-T cell therapy for autoimmune diseases

被引：20

作者：

Li, Yan-Ruide ^{[1
]}

Lyu, Zibai ^{[1
]}

Chen, Yuning ^{[1
]}

Fang, Ying ^{[1
]}

Yang, Lili ^{[1
,2
,3
,4
]}

机构：

[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell R, Los Angeles, CA 90095 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 2024年 / 45卷 / 09期

关键词：

RHEUMATOID-ARTHRITIS PATIENTS; B-CELLS; LEUKEMIA; RITUXIMAB; BELIMUMAB; EFFICACY; ANTIBODY; COLITIS; MODELS; FUTURE;

D O I：

10.1016/j.tips.2024.07.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy has demonstrated significant success in treating cancers. The potential of CAR-T cells is now being explored in the context of autoimmune diseases. Recent clinical trials have shown sustained and profound elimination of autoreactive B cells by CAR-T cells, leading to promising autoimmune disease control with minimal safety concerns. These encouraging results have inspired further investigation into CAR-T cell applications for a broader range of autoimmune diseases and the development of advanced cell products with improved efficacy and safety. In this review, we discuss the mechanisms by which CAR-T cells target autoimmune conditions, summarize current preclinical models, and highlight ongoing clinical trials, including CAR-T therapy design, clinical outcomes, and challenges. Additionally, we discuss the limitations and future directions of CAR-T therapy in the treatment of autoimmune diseases.

引用

页码：839 / 857

页数：19

共 111 条

[31] CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis [J].

Fischbach, Felix ;

Richter, Johanna ;

Pfeffer, Lena Kristina ;

Fehse, Boris ;

Berger, Susanna Carolina ;

Reinhardt, Stefanie ;

Kuhle, Jens ;

Badbaran, Anita ;

Rathje, Kristin ;

Gagelmann, Nico ;

Borie, Dominic ;

Seibel, Johan ;

Ayuk, Francis ;

Friese, Manuel A. ;

Heesen, Christoph ;

Kroeger, Nicolaus .

MED, 2024, 5 (06) :550-558

[32] CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery [J].

Fransson, Moa ;

Piras, Elena ;

Burman, Joachim ;

Nilsson, Berith ;

Essand, Magnus ;

Lu, BinFeng ;

Harris, Robert A. ;

Magnusson, Peetra U. ;

Brittebo, Eva ;

Loskog, Angelica S. I. .

JOURNAL OF NEUROINFLAMMATION, 2012, 9

[33] Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis [J].

Furie, Richard ;

Rovin, Brad H. ;

Houssiau, Frederic ;

Malvar, Ana ;

Teng, Y. K. Onno ;

Contreras, Gabriel ;

Amoura, Zahir ;

Yu, Xueqing ;

Mok, Chi-Chiu ;

Santiago, Mittermayer B. ;

Saxena, Amit ;

Green, Yulia ;

Ji, Beulah ;

Kleoudis, Christi ;

Burriss, Susan W. ;

Barnett, Carly ;

Roth, David A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12) :1117-1128

[34] A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus [J].

Furie, Richard ;

Petri, Michelle ;

Zamani, Omid ;

Cervera, Ricard ;

Wallace, Daniel J. ;

Tegzova, Dana ;

Sanchez-Guerrero, Jorge ;

Schwarting, Andreas ;

Merrill, Joan T. ;

Chatham, W. Winn ;

Stohl, William ;

Ginzler, Ellen M. ;

Hough, Douglas R. ;

Zhong, Z. John ;

Freimuth, William ;

van Vollenhoven, Ronald F. .

ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3918-3930

[35] Recent Advances in Mouse Models of Sjogren's Syndrome [J].

Gao, Yunzhen ;

Chen, Yan ;

Zhang, Zhongjian ;

Yu, Xinhua ;

Zheng, Junfeng .

FRONTIERS IN IMMUNOLOGY, 2020, 11

[36] T-cell development and the CD4-CD8 lineage decision [J].

Germain, RN .

NATURE REVIEWS IMMUNOLOGY, 2002, 2 (05) :309-322

[37] CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies [J].

Gomes-Silva, Diogo ;

Srinivasan, Madhuwanti ;

Sharma, Sandhya ;

Lee, Ciaran M. ;

Wagner, Dimitrios L. ;

Davis, Timothy H. ;

Rouce, Rayne H. ;

Bao, Gang ;

Brenner, Malcolm K. ;

Mamonkin, Maksim .

BLOOD, 2017, 130 (03) :285-296

[38] Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy [J].

Gong, Q ;

Ou, QL ;

Ye, SM ;

Lee, WP ;

Cornelius, J ;

Diehl, L ;

Lin, WY ;

Hu, ZL ;

Lu, YM ;

Chen, YM ;

Wu, Y ;

Meng, YG ;

Gribling, P ;

Lin, ZH ;

Nguyen, K ;

Tran, T ;

Zhang, YF ;

Rosen, H ;

Martin, F ;

Chan, AC .

JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :817-826

[39] CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity [J].

Gupta, Sasha ;

Simic, Milos ;

Sagan, Sharon A. ;

Shepherd, Chanelle ;

Duecker, Jason ;

Sobel, Raymond A. ;

Dandekar, Ravi ;

Wu, Gregory F. ;

Wu, Wesley ;

Pak, John E. ;

Hauser, Stephen L. ;

Lim, Wendell ;

Wilson, Michael R. ;

Zamvil, Scott S. .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (02)

[40]

Haghikia A, 2023, LANCET NEUROL, V22, P1104, DOI [10.1016/s1474-4422(23)00375-7, 10.1016/S1474-4422(23)00375-7]

← 1 2 3 4 5 6 7 8 9 10 →